Decreased expression of cavin-1 in FTC and PTC is in agreement with its downregulation in other tumours including prostate cancer where its expression has been shown to reduce cell migration, tumour growth, angiogenesis and lymphangiogenesis, therefore acting as a potential tumour suppressor45. This evidence concerns the gene CAVIN1 and Familial prostate cancer.